| September 12, 2007 Silvio Ventures Appoints Radvak as Chief Executive Officer | |
| Vancouver, British Columbia, - Silvio Ventures Inc. (TSX-V NEX: SIV.H) and the Board of Directors announced today the appointment of Mr. William J. Radvak as Chief Executive Officer and Chief Financial Officer effective immediately. Mr. Radvak is a co-founder, and past Chief Executive Officer of Response Biomedical Corporation, a publicly listed medical device company that develops and commercializes rapid immunoassay diagnostic tests for use with their proprietary RAMPÒ System for a broad array of clinical and non-clinical applications. Mr. Radvak led the Response Biomedical from its evolution to a 90-employee company and raised in excess of $50 million in public offerings. Mr. Ross Wilmot has resigned as Chief Executive Officer and Chief Financial Officer of the Company and will remain on the Board of Directors of Silvio Ventures Inc. Silvio Ventures Inc. is a publicly traded company, listed on the NEX board of the TSX Venture Exchange under the trading symbol "SIV.H". Silvio Ventures Inc. Contacts: Bill Radvak Chief Executive Officer Tel (778) 888 4101 Email: silvioventures@telus.net | |
You can view the Next News Releases item: Thu Nov 1, 2007, Silvio Announces Board Appointment and Changes in Key Corporate Positions You can view the Previous News Releases item: Mon May 7, 2007, Silvio Ventures Announces Appointment of Brian McAlister to Advisory Committee You can return to the main News Releases page, or press the Back button on your browser. |